## ULTA: Ulta Beauty, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 -0.1% below STRENGTH zone (3.0-6.0%); PEG 2.46 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($575.46)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Capricorn Fund Managers Ltd Acquires Shares of 5,500 Ulta Beauty Inc. $ULTA**
- Source: MarketBeat | 20251228T100849 | Bullish | Relevance: 100%
- Capricorn Fund Managers Ltd initiated a new position in Ulta Beauty (NASDAQ:ULTA) during the third quarter, purchasing 5,500 shares valued at approximately $3.01 million. This move is part of a broader trend of significant institutional interest in Ulta Beauty, with institutional investors and hedge funds owning 90.39% of the stock. Analysts generally maintain a "Moderate Buy" rating for Ulta Beauty, with an average target price of $576.50, following the company's strong Q4 earnings beat and positive FY2025 EPS guidance.

**2. The Beauty of a Turnaround: Why Ulta Beauty is Reclaiming Its Throne in 2025**
- Source: FinancialContent | 20251225T101300 | Bullish | Relevance: 100%
- Ulta Beauty has made a significant turnaround in 2025, reaching near all-time stock highs after facing intense competition. The company diversified its business model, expanded internationally, and redefined its leadership, silencing critics about its growth potential. Ulta's strategic moves, including its "Mass-to-Prestige" assortment and strong loyalty program, have positioned it for continued success despite market risks.

**3. Who Owns Ulta Beauty? Top Shareholders and Recent Insider Trades**
- Source: TIKR.com | 20251226T160831 | Bullish | Relevance: 100%
- This article details the top institutional shareholders of Ulta Beauty (NASDAQ: ULTA), highlighting their holdings and recent adjustments. It also examines hedge fund activities, noting selective increases in exposure by firms like Citadel Advisors and Alyeska Investment Group, and reviews recent insider trades, which appear minor and primarily administrative. Overall, the analysis suggests Ulta Beauty is viewed as a high-quality retailer with stable cash flows, attracting measured positioning from investors.

**4. Swedbank AB Increases Stock Holdings in Ulta Beauty Inc. $ULTA**
- Source: MarketBeat | 20251224T134950 | Bullish | Relevance: 100%
- Swedbank AB significantly increased its stake in Ulta Beauty Inc. during the third quarter, adding 36,456 shares to hold a total of 581,506 shares valued at approximately $318 million. This represents about 1.30% of the company. Ulta Beauty exceeded earnings expectations in its latest quarter and received positive analyst sentiment with a consensus "Moderate Buy" rating and a target price of $576.50.

**5. Texas Permanent School Fund Corp Reduces Stock Position in Ulta Beauty Inc. $ULTA**
- Source: MarketBeat | 20251224T102847 | Somewhat-Bullish | Relevance: 100%
- Texas Permanent School Fund Corp significantly reduced its stake in Ulta Beauty Inc. by 37.3% in Q2, selling 1,873 shares and retaining 3,144 shares valued at approximately $1.47 million. Despite this reduction, Ulta Beauty surpassed earnings expectations, reporting EPS of $5.14 against an estimated $4.61 and revenue of $2.86 billion versus $2.70 billion. Analysts maintain a "Moderate Buy" consensus rating for ULTA, with an average target price of $576.50.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 13, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | Oppenheimer | $675 | $615 | +10% |
| 2025-12-08 | Morgan Stanley | $640 | $600 | +7% |
| 2025-12-08 | TD Cowen | $725 | $600 | +21% |
| 2025-12-05 | DA Davidson | $650 | $625 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | Oppenheimer | main | Outperform |
| 2025-12-08 | Morgan Stanley | main | Overweight |
| 2025-12-08 | TD Cowen | up | Buy |
| 2025-12-05 | DA Davidson | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($0.00M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (+0.6%)
- Blackrock Inc.: 9.0% (-2.1%)
- JPMORGAN CHASE & CO: 5.5% (+99.0%)
- State Street Corpora: 4.4% (+2.3%)
- Sanders Capital, LLC: 2.8% (+8.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 13 raises (avg +6%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 2.46 elevated, pricing in significant growth expectations. Forward P/E 21.5x stretched relative to 11% growth. Quality metrics strong (ROE 48%, ROA 15%). Analyst sentiment positive (13 raises, avg +6%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $27.2B |
| Beta | 0.87 |
| 52W Range | $309.01 - $616.34 |
| Short Interest | 6.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.46 |
| Forward P/E | 21.5 |
| Current P/E | 23.8 |
| YoY Growth | 10.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 stable at -0.1% (minimal 5-day change). Below STRENGTH zone by 3.1pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.60), confirming momentum. OFD pattern: -DBL (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.07% (CS: 73) | Neutral |
| RSI_14 | 64.6 | Neutral |
| MACD Histogram | 0.60 | Bullish |
| vs SMA20 | 1.039x | Above |
| vs SMA50 | 1.114x | Above |
| vs SMA200 | 1.260x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $607.52
- **Stop Loss:** $575.46 (5.3% risk)
- **Target:** $639.58 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 25
- **Position Value:** $15,188.00
- **Portfolio %:** 15.19%
- **Risk Dollars:** $825.00
- **Risk Per Trade:** 0.83%
- **Modifiers:** L1 110% | L2 75% | Combined 0.83x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

**Next:** 2026-03-12 (Est: $7.15)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $4.60 | $5.14 | +11.7% |
| 2025Q3 | $5.04 | $5.78 | +14.6% |
| 2025Q2 | $5.80 | $6.70 | +15.5% |
| 2025Q1 | $7.15 | $8.46 | +18.4% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*